ES2058129T3 - Composiciones farmaceuticas que comprenden una solucion acuosa de un derivado de piranoquinolina. - Google Patents

Composiciones farmaceuticas que comprenden una solucion acuosa de un derivado de piranoquinolina.

Info

Publication number
ES2058129T3
ES2058129T3 ES87310882T ES87310882T ES2058129T3 ES 2058129 T3 ES2058129 T3 ES 2058129T3 ES 87310882 T ES87310882 T ES 87310882T ES 87310882 T ES87310882 T ES 87310882T ES 2058129 T3 ES2058129 T3 ES 2058129T3
Authority
ES
Spain
Prior art keywords
alternative
diseases
aqueous solution
disease
pharmaceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87310882T
Other languages
English (en)
Inventor
Andrew Reginald Clark
Julia Helena Ratcliffe
Paul Wright
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fisons Ltd
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868630769A external-priority patent/GB8630769D0/en
Priority claimed from GB868630767A external-priority patent/GB8630767D0/en
Priority claimed from GB868630904A external-priority patent/GB8630904D0/en
Priority claimed from GB878706684A external-priority patent/GB8706684D0/en
Application filed by Fisons Ltd filed Critical Fisons Ltd
Application granted granted Critical
Publication of ES2058129T3 publication Critical patent/ES2058129T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

USE DE ACIDO 9-ETIL-6,9-DIHIDRO-4,6-DIOXO-10-PROPIL-4H- PIRANO (3,2)G QUINOLEIN-2,8-DICARBOXILICO O UNA SAL FARMACOLOGICAMENTE ACEPTABLE DEL MISMO, EN LA FABRICACION DE UNA SOLUCION ACUOSA PARA EL TRATAMIENTO DE UNA ALTERACION SELECCIONADA ENTRE EL GRUPO FORMADO POR: CONJUNTIVITIS, QUERATITIS, "OJOS ALERGICOS", INFECCIONES POR ADENOVIRUS, RECHAZO AL HOMOINJERTO DE CORNEA, UVEITIS ANTERIOR, POLIPOS NASALES, RINITIS VASOMOTORA, MANIFESTACIONES ALERGICAS NASOFARINGEAS, ENFERMEDAD ABSTRUCTIVA REVERSIBLE DE LAS VIAS RESPIRATORIAS, ENFERMEDAD DE CROHN, COLITIS DISTAL Y PROCTITIS. TAMBIEN SE DESCRIBEN NUEVAS FORMULACIONES FARMACOLOGICAS Y METODOS PARA SU FABRICACION.
ES87310882T 1986-12-23 1987-12-10 Composiciones farmaceuticas que comprenden una solucion acuosa de un derivado de piranoquinolina. Expired - Lifetime ES2058129T3 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB868630769A GB8630769D0 (en) 1986-12-23 1986-12-23 Pharmaceutical formulation
GB868630767A GB8630767D0 (en) 1986-12-23 1986-12-23 Pharmaceutical formulation
GB868630904A GB8630904D0 (en) 1986-12-24 1986-12-24 Pharmaceutical formulation
GB878706684A GB8706684D0 (en) 1987-03-20 1987-03-20 Pharmaceutical formulation

Publications (1)

Publication Number Publication Date
ES2058129T3 true ES2058129T3 (es) 1994-11-01

Family

ID=27449862

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87310882T Expired - Lifetime ES2058129T3 (es) 1986-12-23 1987-12-10 Composiciones farmaceuticas que comprenden una solucion acuosa de un derivado de piranoquinolina.

Country Status (22)

Country Link
US (1) US5443833A (es)
EP (1) EP0279121B1 (es)
JP (2) JP2568233B2 (es)
KR (1) KR960001370B1 (es)
AU (1) AU595969B2 (es)
BE (2) BE1002179A5 (es)
CA (1) CA1296635C (es)
CH (1) CH674937A5 (es)
DE (1) DE3787274T2 (es)
DK (1) DK175032B1 (es)
ES (1) ES2058129T3 (es)
FI (1) FI875616L (es)
FR (1) FR2609392B1 (es)
GR (1) GR871999B (es)
IE (3) IE940371L (es)
IL (1) IL84893A (es)
LU (1) LU87087A1 (es)
MY (1) MY101535A (es)
NO (1) NO875359L (es)
NZ (1) NZ223026A (es)
PT (1) PT86455B (es)
SA (1) SA90110074B1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8704773D0 (en) * 1987-02-28 1987-04-01 Fisons Plc Compounds
GB2202145B (en) * 1987-03-17 1991-01-02 Fisons Plc Compositions of nedocromil for dermatological use.
GB8727590D0 (en) * 1987-11-25 1987-12-31 Fisons Plc Formulation
US5976573A (en) 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
US7977376B2 (en) 2001-06-27 2011-07-12 Novartis Ag Olopatadine formulations for topical nasal administration
EP2506711B1 (en) * 2009-12-03 2019-04-03 OPKO Health, Inc. Hypersulfated disaccharide formulations

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4474787A (en) * 1977-05-04 1984-10-02 Fisons Limited 7,6 Dioxo-4H,6H-pyrano[3,2-g]quinoline dicarboxylic acids and anti-allergic use thereof
ZA782473B (en) * 1977-05-04 1979-04-25 Fisons Ltd Benzo pyrano-quinolinones
IL54614A (en) * 1977-05-04 1983-07-31 Fisons Ltd Dihydrodioxo-pyranoquinoline dicarboxylic acid derivatives,their production and pharmaceutical compositions containing them
FR2440371A1 (fr) * 1978-10-31 1980-05-30 Fisons Ltd Nouveaux composes azotes heterocycliques, des compositions pharmaceutiques en contenant et des procedes pour les preparer
EP0030423B1 (en) * 1979-12-07 1985-02-13 FISONS plc A process for the production of 1,4-dihydro-4-oxo-quinoline-2-carboxylic acids, or salts, esters or amides thereof and intermediates therefor
AU8468782A (en) * 1981-06-25 1983-01-06 Fisons Plc Compounds with sodium cromoglycate activity
GB8402047D0 (en) * 1984-01-26 1984-02-29 Fisons Plc Nitrogen heterocycles
DE3584580D1 (de) * 1984-04-13 1991-12-12 Fisons Plc Formen und formulierungen des nedocromil-natriumsalzes.
GB8630419D0 (en) * 1986-12-19 1987-01-28 Fisons Plc Pharmaceutical formulation
GB8704089D0 (en) * 1987-02-21 1987-03-25 Fisons Plc Method of treatment
GB8704773D0 (en) * 1987-02-28 1987-04-01 Fisons Plc Compounds
GB2202145B (en) * 1987-03-17 1991-01-02 Fisons Plc Compositions of nedocromil for dermatological use.

Also Published As

Publication number Publication date
FR2609392B1 (fr) 1994-04-08
JPH07231926A (ja) 1995-09-05
DK680787A (da) 1988-06-24
JP2568233B2 (ja) 1996-12-25
DK175032B1 (da) 2004-05-03
GR871999B (en) 1988-04-26
IE63213B1 (en) 1995-04-05
DK680787D0 (da) 1987-12-22
FI875616A0 (fi) 1987-12-21
US5443833A (en) 1995-08-22
IL84893A0 (en) 1988-06-30
JP2504926B2 (ja) 1996-06-05
AU8292987A (en) 1988-06-23
IE940371L (en) 1988-06-23
CA1296635C (en) 1992-03-03
BE1002179A5 (fr) 1990-10-02
PT86455A (en) 1988-01-01
CH674937A5 (es) 1990-08-15
FI875616A7 (fi) 1988-06-24
KR880007082A (ko) 1988-08-26
BE1003466A3 (fr) 1992-03-31
EP0279121A3 (en) 1990-09-12
FI875616L (fi) 1988-06-24
EP0279121B1 (en) 1993-09-01
DE3787274T2 (de) 1994-01-27
IE940372L (en) 1988-06-23
NO875359L (no) 1988-06-24
JPS63233918A (ja) 1988-09-29
MY101535A (en) 1991-11-30
NO875359D0 (no) 1987-12-21
IE873507L (en) 1988-06-23
NZ223026A (en) 1989-09-27
EP0279121A2 (en) 1988-08-24
DE3787274D1 (de) 1993-10-07
FR2609392A1 (fr) 1988-07-15
IL84893A (en) 1991-11-21
KR960001370B1 (ko) 1996-01-26
LU87087A1 (fr) 1989-07-07
PT86455B (pt) 1990-11-20
AU595969B2 (en) 1990-04-12
SA90110074B1 (ar) 2006-03-06

Similar Documents

Publication Publication Date Title
Villeneuve The Rabbit Syndrome a peculiar extrapyramidal reaction
RU94002475A (ru) Фармацевтическая композиция и ее применение для лечения вирусных инфекций
US20090191288A1 (en) Composition to Treat Herpes, Pseudomonas, Staph, Hepatitis and Other Infectious Diseases
BG86132A (bg) Производни на пиридазинамин
MX9203543A (es) Medicamento.
PT88985A (pt) Processo para a preparacao de composicoes farmaceuticas nasais e ou oftalmicas contendo azelastina
ES2061727T3 (es) Sustancias fisiologicamente activas, un procedimiento para su preparacion y composiciones farmaceuticas que las contienen.
US20170258861A1 (en) Treatment of Herpes, Pseudomonas, Staph, and Hepatitis
ES2153906T3 (es) Uso de incienso para el tratamiento de la enfermedad de alzheimer.
DE60018409D1 (de) Verwendung von antiseptika zur herstelllung von arzneimitteln zur prophylaxe und behandlung von infektionen und/ oder funktionellen gewebeumformungen im körperinneren
ES2058129T3 (es) Composiciones farmaceuticas que comprenden una solucion acuosa de un derivado de piranoquinolina.
MX157054A (es) Procedimiento para preparar derivados de disenzoxazepina
Flaxman Myocardial abscess
Cornbleet Discoid Lupus Erythematosus Treated with Plaguenil
RU2071316C1 (ru) Глазные капли для лечения катаракты
Lang, R. & Walker Toxic epidermal necrolysis-a report of four cases
McTaggart Poisoning due to sodium fluoroacetate (“1080”)
Mahrer et al. Atropine-like poisoning due to tranquilizing agents
RU2030179C1 (ru) Антимикробное и антигрибковое средство "blus"
KR100408928B1 (ko) 알로에신을 함유하는 허혈성 질환의 예방 및 치료용조성물, 및 이를 포함하는 제제
Drinkwater Fifty years of medical progress, 1873-1922
Schnitzer et al. Chemical and toxicological studies on phenothiazine
du Toit, R. & Meyer A case in South Africa of ocular myiasis in man due to the first stage larvae of the nasal bot fly of the sheep (Oestrus ovis L.)
SU577031A1 (ru) Анестетик дл поверхностной анестезии в глазной и отоларингологической "практике" бензодиокаин
JPS568324A (en) Infectious disease remedy for external and ophthalmologic application

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 279121

Country of ref document: ES